Please login to the form below

Not currently logged in
Email:
Password:

patient engagement

This page shows the latest patient engagement news and features for those working in and with pharma, biotech and healthcare.

Indigo Medical joins imc group

Indigo Medical joins imc group

With the addition of Indigo, imc group will now offer services for clients across seven core divisions, including medical &scientific content, publications, digital &creative, insights &consulting, patient engagement, meetings &events and

Latest news

  • Fishawack Health adds The Hive Health Group to its network Fishawack Health adds The Hive Health Group to its network

    The agency has a particular focus on strategy, scientific storytelling and innovative patient engagement. ... We’re excited to add Hive Health to the group – a strategically led healthcare communications brand with outstanding expertise in patient

  • Launch leaders' blog: what should launch leaders be measuring? Launch leaders' blog: what should launch leaders be measuring?

    Are we truly engaging and changing the knowledge, attitudes and behaviours of target customers in order to improve patient outcomes? ... Engagement and support of the patient advocacy community and media. Internal launch team belief in the success of the

  • Q&A: Vicky Bramham Q&A: Vicky Bramham

    What has been your career highlight to date? Joining OPEN Health Patient &Brand Communications and working in such a multi- disciplinary environment. ... I’ve learnt so many new perspectives in a matter of months working closely alongside colleagues in

  • Syneos Health announces partnership with AiCure Syneos Health announces partnership with AiCure

    Will leverage proprietary intelligent software and AI-driven insights. Syneos Health, an integrated biopharmaceutical solutions organisation, has partnered with AiCure for smarter clinical trials that optimise patient engagement. . ... By deploying the

  • SMC approves Yescarta and Keytruda, rejects Perjeta SMC approves Yescarta and Keytruda, rejects Perjeta

    The SMC has approved Yescarta for the treatment for adults patients with certain types of lymphoma as a second-line therapy through its Patient and Clinician Engagement (PACE) process.

More from news
Approximately 25 fully matching, plus 95 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 26 fully matching, plus 63 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 91 fully matching, plus 120 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics